Alameda Health System: Clinical Trials

9 trials sponsored by Alameda Health System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 recruiting, 1 unknown. 3 Not applicable, 3 Phase 4, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 43Completed 2, Recruiting 1
Phase 22Completed 1, Unknown 1
Phase 31Recruiting 1

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Does Style of Pre-sedation Instructions Improve Patient Outcomes in Ambulatory Anesthesia for Oral and Maxillofacial Surgery?
Guided visualization and standardized pre-sedation instructions, Standardized pre-sedation instructions only - Anesthesia Outcomes, Anesthesia Complication
Not applicableCompletedAlameda Health System1282025-01-022026-04-30
Standard Versus High Dose ED-Initiated Buprenorphine Induction
Buprenorphine - Opioid Use Disorder
Phase 3RecruitingYale University3602024-12-062026-05-28
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
SUN, SUN + Telebridge, ED-ITT - Opioid Use Disorder
Not applicableRecruitingRAND5002024-10-042026-02-19
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
Methadone, Buprenorphine (BUP) - Opioid Use Disorder
Phase 4RecruitingYale University6002024-06-042026-09-14
Facilitating Adaptive Expertise in Learning Computed Tomography
Error Management Training (Difficult), Error Management Training (Easy), Error Avoidance Training - Adaptive Expertise, Error Management Training
Not applicableCompletedStanford University1502022-07-182024-04-02
Emergency Department-Initiated Buprenorphine Validation Network Trial
CAM2038, Buprenorphine Sublingual Product - Opioid-use Disorder
Phase 2CompletedYale University20002020-07-082025-01-10
Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department
Buprenorphine, Morphine Sulfate - Pain
Phase 2UnknownAlameda Health System1222017-09-262017-10-19
Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department
Ketamine IV Infusion, Ketamine IV push - Pain
Phase 4CompletedAlameda Health System622016-09-012020-04-17
Intravenous Lidocaine Versus Morphine for Severe Pain in the ED
Intravenous lidocaine, Intravenous morphine - Pain
Phase 4CompletedAlameda Health System322016-03-012020-04-06

Conditions studied

Opioid-Related Disorders (4)  ·  Pain (3)  ·  Crying (1)  ·  Emergencies (1)  ·  Facies (1)  ·  Motor Activity (1)

Interventions

Buprenorphine (4)  ·  Morphine (2)  ·  Breath Holding (1)  ·  Buprenorphine, Naloxone Drug Combination (1)  ·  Ketamine (1)  ·  Lidocaine (1)  ·  Methadone (1)  ·  Solar System (1)

Countries

United States (9)

Top investigators

David Fiellin, MD (2)  ·  Gail D'Onofrio, MD, MS (2)  ·  Andrew Herring, MD (1)  ·  Kathryn Hawk (1)  ·  Leonardo Aliaga, MD (1)

Results publications

PMID 29645317, PMID 36400184, PMID 38976265, PMID 39250155, PMID 41670966, PMID 42236100

NIH funding

2UG1DA015831-19 (1), 5UG1DA015831-21 (1), UG1DA015831 (1)